Study Uncovers NK Cell-Based Combination Immunotherapies for Multiple Myeloma
A new study, published in The Journal of Immunology, uncovered approaches to enhance Natural Killer (NK) cellular therapy for patients with multiple myeloma.
A new study, published in The Journal of Immunology, uncovered approaches to enhance Natural Killer (NK) cellular therapy for patients with multiple myeloma.
The Journal of Immunology and ImmunoHorizons offers new resources through exciting publishing partnership with Oxford University Press.
Members of The American Association of Immunologists are among the authors of a report on the dangers of mirror life research, highlighting the importance of this discussion to immunology.
A new study published in The Journal of Immunology has found that maternal infection with parasitic worms, or helminths, affects the immune system of male offspring.
Former ImmunoHorizons Editor-in-Chief Mark Kaplan has penned a final editorial title ‘Oh, The Papers We Publish’ about his experiences with…
Mark Kaplan, outgoing Editor-in-Chief of ImmunoHorizons, reflects on his time with the journal and where he sees open-access heading.
AAI member, Deepta Bhattacharya, talks to us about the new Center for Advanced Molecular and Immunological Therapies (CAMI) at the University of Arizona.
AAI proudly announces the appointment of Bonnie N. Dittel, Ph.D., as the new editor-in-chief of ImmunoHorizons. Dr. Dittel’s five-year term will commence on January 1, 2025, and end on December 31, 2029.
Unlike legitimate society publishers, one of the red flags of a predatory publisher is insufficient communication with journal staff. Often, responses from predatory publishers leave you with more questions than answers.
Predatory publishers are finding creative ways to mimic legitimate author-outreach efforts. They are using language in their communications and on their websites that can be misleading to the untrained eye.